MAY 05, 2017 5:18 AM PDT

How a Cancer-Causing Virus Hides in Plain Sight

WRITTEN BY: Xuan Pham

It’s estimated that nine out of ten people are infected with the Epstein-Barr virus (EBV). The virus stays dormant for most of the time, but in some cases, it rears its ugly self to cause lymphoma in immunocompromised people. How does the virus manage to conceal itself so well within our bodies only to strike when we’re most vulnerable? Scientists think it’s the virus’ ability to masquerade within our immune cells.

Image credit: wikipedia.org

Since its discovery in the 1960s, the Epstein-Barr virus has proven to be increasingly more complex. Also called human herpesvirus 4 (HHV-4), EBV is one of eight viruses in the herpes family. It’s infamous for causing “the kissing disease,” otherwise known as mono (short for mononucleosis), in teenagers.

But even more threatening than causing swollen lymph glands and fevers, EBV was the first virus shown to cause cancer directly. In particular, EBV infection is linked to two types of lymphomas (Burkitt’s and Hodgkin’s), stomach cancer, and some types of head and neck cancer (nasopharyngeal carcinoma).

EBV typically persists in a type of immune cells called B cells - these are white blood cells that respond to infection. And from within, the virus manages to boost B cell division while simultaneously stalling cell death.

"The virus actually taps into the B cell's normal protection against apoptosis," said Micah Luftig, an associate professor of molecular genetics and microbiology at Duke University, and the study's senior investigator.

By this mechanism, EBV manages to immortalize the B cells, and thereby furthering its own survival. Specifically, as the infection progresses, EBV will blend in with memory B cells, a B-cell subtype that circulate throughout the body, ready to respond to attacks by known pathogens.

"All of this is about establishing latency," Luftig said. This is how EBV hides in plain sight. The team used a technique called BH3 profiling to “query mitochondrial regulation of apoptosis,” which allowed them to glimpse the mechanism behind B-cell immortalization by the virus. Key to the story is a protein called EBNA3A (Epstein-Barr Nuclear Antigen 3A), which plays an crucial role in the B cell’s abilities to resist apoptosis.

Ultimately, Luftig hopes this line of research could lead to new treatment options and benefit immunocompromised people who are at much higher risk of developing cancer from the Epstein-Barr virus.

Additional source: Duke University via EurekAlert!

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JAN 19, 2021
Cancer
Report on alcohol-related cancer incidence and mortality by state
JAN 19, 2021
Report on alcohol-related cancer incidence and mortality by state
New research published in Cancer Epidemiology suggests that alcohol consumption is associated with cancer incidence and ...
JAN 23, 2021
Cancer
Quantifying delays in radiotherapy during the pandemic
JAN 23, 2021
Quantifying delays in radiotherapy during the pandemic
Researchers from the University of Leeds, Public Health England, and the Royal College of Radiologists have investigated ...
FEB 09, 2021
Clinical & Molecular DX
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
FEB 09, 2021
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
A clearly defined border differentiates benign tumors from malignant ones. Malignant tumors start to get fuzzy around th ...
FEB 03, 2021
Cancer
What can cancer in sea lions teach us about ourselves?
FEB 03, 2021
What can cancer in sea lions teach us about ourselves?
New research from a 20-year long study on California sea lions shows cause for alarm for both ecologists and oncologists ...
MAR 19, 2021
Cancer
What does RNA editing do to the immune system?
MAR 19, 2021
What does RNA editing do to the immune system?
A recent study published in the journal Nature Communications from the University of Colorado Cancer Center explores new ...
APR 01, 2021
Plants & Animals
Scientists Solve Sea Lion Cancer Mystery
APR 01, 2021
Scientists Solve Sea Lion Cancer Mystery
For more than thirty years, scientists have tried to solve the mystery of the high prevalence of cancer among wild Calif ...
Loading Comments...